{"id":"https://openalex.org/W2964098540","doi":"https://doi.org/10.1001/jamaoncol.2019.1747","title":"Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non\u2013Small Cell Lung Cancer","display_name":"Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non\u2013Small Cell Lung Cancer","alternate_titles":[],"publication_year":2019,"publication_date":"2019-07-25","ids":{"openalex":"https://openalex.org/W2964098540","doi":"https://doi.org/10.1001/jamaoncol.2019.1747","mag":"2964098540","pmid":"https://pubmed.ncbi.nlm.nih.gov/31343662","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6659150"},"language":"en","primary_location":{"id":"doi:10.1001/jamaoncol.2019.1747","doi":"https://doi.org/10.1001/jamaoncol.2019.1747","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaoncol.2019.1747","pdf_url":"https://jamanetwork.com/journals/jamaoncology/articlepdf/2738768/jamaoncology_kazandjian_2019_br_190004.pdf","source":{"id":"https://openalex.org/S2756165422","display_name":"JAMA Oncology","issn_l":"2374-2437","issn":["2374-2437","2374-2445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2964098540"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://jamanetwork.com/journals/jamaoncology/articlepdf/2738768/jamaoncology_kazandjian_2019_br_190004.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048966043","display_name":"Dickran Gano Kazandjian","orcid":"https://orcid.org/0000-0002-6593-0917","observed_orcids":["https://orcid.org/0000-0002-6593-0917"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Dickran Kazandjian","raw_affiliation_strings":["Myeloma Program, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland","Oncology Center of Excellence, Office of Hematology and Oncology Products, US Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Program, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"Oncology Center of Excellence, Office of Hematology and Oncology Products, US Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108756241","display_name":"Yutao U. T. Gong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yutao Gong","raw_affiliation_strings":["Oncology Center of Excellence, Office of Hematology and Oncology Products, US Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Center of Excellence, Office of Hematology and Oncology Products, US Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077268765","display_name":"Patricia Keegan","orcid":"https://orcid.org/0000-0002-7266-395X","observed_orcids":["https://orcid.org/0000-0002-7266-395X"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia Keegan","raw_affiliation_strings":["Oncology Center of Excellence, Office of Hematology and Oncology Products, US Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Center of Excellence, Office of Hematology and Oncology Products, US Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051520990","display_name":"Richard Pazdur","orcid":"https://orcid.org/0000-0002-4771-9923","observed_orcids":["https://orcid.org/0000-0002-4771-9923"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Pazdur","raw_affiliation_strings":["Oncology Center of Excellence, Office of Hematology and Oncology Products, US Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Center of Excellence, Office of Hematology and Oncology Products, US Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029612220","display_name":"Gideon Michael Blumenthal","orcid":"https://orcid.org/0000-0002-1264-129X","observed_orcids":["https://orcid.org/0000-0002-1264-129X"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gideon M. Blumenthal","raw_affiliation_strings":["Oncology Center of Excellence, Office of Hematology and Oncology Products, US Food and Drug Administration, Silver Spring, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Center of Excellence, Office of Hematology and Oncology Products, US Food and Drug Administration, Silver Spring, Maryland","institution_ids":["https://openalex.org/I1320320070"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5048966043"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1320320070","https://openalex.org/I4210140884","https://openalex.org/I4210149717"],"apc_list":null,"apc_paid":null,"fwci":13.7041,"has_fulltext":true,"cited_by_count":247,"citation_normalized_percentile":{"value":0.992881,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"5","issue":"10","first_page":"1481","last_page":"1481"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.015799999237060547,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lung-immune-prognostic-index","display_name":"lung immune prognostic index","score":0.9779999852180481},{"id":"https://openalex.org/keywords/metastatic-nsclc","display_name":"metastatic non-small cell lung cancer","score":0.9639999866485596},{"id":"https://openalex.org/keywords/neutrophil-to-lymphocyte-ratio","display_name":"neutrophil-to-lymphocyte ratio","score":0.9490000009536743},{"id":"https://openalex.org/keywords/lactate-dehydrogenase","display_name":"lactate dehydrogenase","score":0.996999979019165},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8700000047683716},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9900000095367432},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.9909999966621399},{"id":"https://openalex.org/keywords/conventional-chemotherapy","display_name":"cytotoxic chemotherapy","score":0.8399999737739563},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8709999918937683},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.6800000071525574},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-related-pneumonitis","display_name":"immune-related pneumonitis","score":0.6940000057220459},{"id":"https://openalex.org/keywords/immune-mediated-colitis","display_name":"immune-related colitis","score":0.6809999942779541},{"id":"https://openalex.org/keywords/immune-related-endocrinopathy","display_name":"immune-related endocrinopathy","score":0.5870000123977661},{"id":"https://openalex.org/keywords/immune-related-hypothyroidism","display_name":"immune-related hypothyroidism","score":0.460999995470047}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9352449178695679},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7357866168022156},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.7179275751113892},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6082566380500793},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5624602437019348},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.4941273033618927},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.43658921122550964},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.43652305006980896},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.33627933263778687},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.25842487812042236}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1001/jamaoncol.2019.1747","doi":"https://doi.org/10.1001/jamaoncol.2019.1747","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaoncol.2019.1747","pdf_url":"https://jamanetwork.com/journals/jamaoncology/articlepdf/2738768/jamaoncology_kazandjian_2019_br_190004.pdf","source":{"id":"https://openalex.org/S2756165422","display_name":"JAMA Oncology","issn_l":"2374-2437","issn":["2374-2437","2374-2445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncology","raw_type":"journal-article"},{"id":"pmid:31343662","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31343662","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6659150","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6659150/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1001/jamaoncol.2019.1747","doi":"https://doi.org/10.1001/jamaoncol.2019.1747","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaoncol.2019.1747","pdf_url":"https://jamanetwork.com/journals/jamaoncology/articlepdf/2738768/jamaoncology_kazandjian_2019_br_190004.pdf","source":{"id":"https://openalex.org/S2756165422","display_name":"JAMA Oncology","issn_l":"2374-2437","issn":["2374-2437","2374-2445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2964098540.pdf","grobid_xml":"https://content.openalex.org/works/W2964098540.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W2514084143","https://openalex.org/W2772599579","https://openalex.org/W2783295481","https://openalex.org/W2784283849","https://openalex.org/W2785431528","https://openalex.org/W2792273180","https://openalex.org/W2797011267","https://openalex.org/W2802496191","https://openalex.org/W2898246735","https://openalex.org/W4233854028"],"related_works":["https://openalex.org/W2890088156","https://openalex.org/W4323360581","https://openalex.org/W4368342901","https://openalex.org/W3135352622","https://openalex.org/W2985198865","https://openalex.org/W4399868694","https://openalex.org/W2995533566","https://openalex.org/W2978141300","https://openalex.org/W4390615321","https://openalex.org/W4395465567"],"abstract_inverted_index":{"IMPORTANCE:":[0],"Previous":[1],"studies":[2,79],"have":[3],"suggested":[4],"the":[5,8,67,101,117,145,148,173,175,377,380],"importance":[6],"of":[7,77,80,100,312,362,379],"baseline":[9,352],"derived":[10],"neutrophil":[11],"to":[12,32,116,154],"lymphocyte":[13],"ratio":[14],"(dNLR)":[15],"and":[16,39,82,113,120,127,147,158,166,183,196,198,233,249,280,328,355],"lactate":[17],"dehydrogenase":[18],"(LDH)":[19],"level":[20,150,354],"as":[21],"prognostic":[22,27,138,206,359],"markers.":[23],"The":[24,351],"lung":[25,49],"immune":[26,54,137],"index":[28,139],"(LIPI)":[29],"was":[30,98,258],"shown":[31],"be":[33,384],"associated":[34,70,259],"with":[35,45,53,71,88,134,201,219,260,302,367],"progression-free":[36],"survival":[37,41,195],"(PFS)":[38],"overall":[40],"(OS)":[42],"among":[43,263],"patients":[44,87,133,218,230,235,246,251,264,366],"metastatic":[46],"non-small":[47],"cell":[48],"cancer":[50],"(mNSCLC)":[51],"treated":[52],"checkpoint":[55],"inhibitors":[56],"(ICIs)":[57],"but":[58],"not":[59],"cytotoxic":[60],"chemotherapy":[61],"(CCT).":[62],"OBJECTIVE:":[63],"To":[64],"determine":[65],"whether":[66],"LIPI":[68,102,207,256,304,381],"is":[69,375],"long-term":[72],"outcomes":[73],"in":[74,288,297,310,336,345],"pooled":[75,96],"analyses":[76],"clinical":[78,108,372],"ICI":[81,224,289,337],"targeted":[83],"therapy":[84],"(TT)":[85],"for":[86,131,172,365],"mNSCLC.":[89,135,368],"DESIGN,":[90],"SETTING,":[91],"AND":[92,192,349],"PARTICIPANTS:":[93],"An":[94],"exploratory":[95],"analysis":[97],"performed":[99],"on":[103,144],"data":[104],"from":[105],"11":[106],"randomized":[107,212],"multinational":[109],"trials":[110,213,225,241],"evaluating":[111],"ICIs":[112,232,266],"TT":[114,240,248,273,298,346],"submitted":[115],"US":[118],"Food":[119],"Drug":[121],"Administration":[122],"between":[123],"January":[124],"1,":[125],"2013,":[126],"December":[128],"31,":[129],"2017,":[130],"4914":[132],"Lung":[136],"scores":[140],"were":[141,170,214,308],"calculated":[142],"based":[143],"dNLR":[146,356],"LDH":[149,176,353],"per":[151],"previous":[152],"publications":[153],"generate":[155],"good,":[156,202],"intermediate,":[157,203],"poor":[159,205,303],"composite":[160],"scores.":[161,208,305],"Multivariable":[162],"Cox":[163],"proportional":[164],"PFS":[165,197,313],"OS":[167,262],"hazard":[168,291,315,322,330,339],"ratios":[169],"generated":[171],"dNLR,":[174],"level,":[177],"age,":[178],"smoking":[179],"status,":[180],"histologic":[181],"characteristics,":[182],"Eastern":[184],"Cooperative":[185],"Oncology":[186],"Group":[187],"performance":[188],"score.":[189],"MAIN":[190],"OUTCOMES":[191],"MEASURES:":[193],"Overall":[194],"their":[199],"association":[200],"or":[204],"RESULTS:":[209],"Eleven":[210],"mNSCLC":[211],"analyzed,":[215],"including":[216],"3987":[217],"available":[220],"data.":[221],"In":[222,238],"5":[223],"comprising":[226,242],"2440":[227],"patients,":[228,244],"1368":[229],"received":[231,236,247,252],"1072":[234],"CCT.":[237,253],"6":[239],"1547":[243],"1110":[245],"437":[250],"A":[254],"good":[255],"score":[257,382],"better":[261,385],"receiving":[265],"(hazard":[267,274,282],"ratio,":[268,275,283,292,316,323,331,340],"0.34;":[269],"95%":[270,277,285,294,318,325,333,342],"CI,":[271,278,286,295,319,326,334,343],"0.28-0.42),":[272],"0.28;":[276],"0.21-0.37),":[279],"CCT":[281],"0.49;":[284],"0.40-0.60":[287],"trials;":[290,338],"0.41;":[293],"0.27-0.61":[296],"trials)":[299],"than":[300],"those":[301],"Similar":[306],"findings":[307],"observed":[309],"terms":[311],"(ICIs:":[314],"0.59;":[317],"0.48-0.72;":[320],"TT:":[321],"0.46;":[324],"0.37-0.57;":[327],"CCT:":[329],"0.56;":[332],"0.45-0.68":[335],"0.51;":[341],"0.38-0.69":[344],"trials).":[347],"CONCLUSIONS":[348],"RELEVANCE:":[350],"are":[357],"important":[358],"biomarkers":[360],"irrespective":[361],"treatment":[363],"modality":[364],"As":[369],"further":[370],"prospective":[371],"trial":[373],"information":[374],"collected,":[376],"role":[378],"can":[383],"defined.":[386]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2964098540","counts_by_year":[{"year":2026,"cited_by_count":23},{"year":2025,"cited_by_count":14},{"year":2024,"cited_by_count":41},{"year":2023,"cited_by_count":41},{"year":2022,"cited_by_count":33},{"year":2021,"cited_by_count":62},{"year":2020,"cited_by_count":27},{"year":2019,"cited_by_count":5}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2019-07-30T00:00:00"}
